CStone Pharmaceuticals (FRA:PH4)
0.5800
-0.0050 (-0.85%)
Last updated: Jan 28, 2026, 3:25 PM CET
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of €852.14 million as of January 30, 2026. Its market cap has increased by 143.08% in one year.
Market Cap
852.14M
Enterprise Value
816.86M
Revenue
24.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.58
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 1.42B to 852.14M, a decrease of -39.93%. That is a compound annual growth rate of -7.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 852.14M | 0.36% |
| Dec 31, 2025 | 849.07M | 132.56% |
| Dec 31, 2024 | 365.09M | 9.00% |
| Dec 29, 2023 | 334.93M | -49.41% |
| Dec 30, 2022 | 662.04M | -39.03% |
| Dec 31, 2021 | 1.09B | -11.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |
| Maschinenfabrik Berthold Hermle AG | 787.50M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 701.68M |
| FRoSTA Aktiengesellschaft | 656.73M |